Literature DB >> 15546397

The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation.

Michael P Cancro1.   

Abstract

Discovery and characterization of the tumor necrosis factor (TNF) family member B-lymphocyte stimulator (BLyS) has opened a novel chapter in the role of TNF family members in the homeostatic control of lymphocyte populations. BLyS and its sister cytokine APRIL (a proliferation-inducing ligand) act primarily as soluble trimers and serve to regulate the steady-state numbers of nearly all B-cell compartments. This homeostatic regulation is accomplished through the regulation of B-cell production rates, selection thresholds, and lifespan. Differential expression of the three BLyS receptors during differentiation and activation provides related yet distinct homeostatic niches for follicular, marginal zone, and memory B-cell subsets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546397     DOI: 10.1111/j.0105-2896.2004.00212.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  20 in total

1.  Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI.

Authors:  Amaya I Wolf; Krystyna Mozdzanowska; William J Quinn; Michele Metzgar; Katie L Williams; Andrew J Caton; Eric Meffre; Richard J Bram; Loren D Erickson; David Allman; Michael P Cancro; Jan Erikson
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

Review 2.  New roles for the BLyS/BAFF family in antigen-experienced B cell niches.

Authors:  Radhika Goenka; Jean L Scholz; Vishal J Sindhava; Michael P Cancro
Journal:  Cytokine Growth Factor Rev       Date:  2014-01-10       Impact factor: 7.638

3.  Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF.

Authors:  Daniela Frasca; Richard L Riley; Bonnie B Blomberg
Journal:  Exp Gerontol       Date:  2006-10-25       Impact factor: 4.032

4.  Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.

Authors:  Irina Debnath; Kirstin M Roundy; Janis J Weis; John H Weis
Journal:  Mol Immunol       Date:  2006-11-30       Impact factor: 4.407

Review 5.  The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity.

Authors:  M P Cancro
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 6.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

7.  Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals.

Authors:  Almut Meyer-Bahlburg; Ashok D Bandaranayake; Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.

Authors:  Luis Sanchez-Perez; Bryan D Choi; Elizabeth A Reap; Elias J Sayour; Pamela Norberg; Robert J Schmittling; Gerald E Archer; James E Herndon; Duane A Mitchell; Amy B Heimberger; Darell D Bigner; John H Sampson
Journal:  Cancer Immunol Immunother       Date:  2013-04-17       Impact factor: 6.968

9.  Similarities and differences between selective and nonselective BAFF blockade in murine SLE.

Authors:  Meera Ramanujam; Xiaobo Wang; Weiqing Huang; Zheng Liu; Lena Schiffer; Haiou Tao; Daniel Frank; Jeffrey Rice; Betty Diamond; Karl O A Yu; Steven Porcelli; Anne Davidson
Journal:  J Clin Invest       Date:  2006-02-16       Impact factor: 14.808

Review 10.  Resolve, revise, and relax: the 3 Rs of B cell repertoire adjustment.

Authors:  Jean L Scholz; Michael P Cancro
Journal:  Immunol Lett       Date:  2012-02-06       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.